Emmanuel Hanon

3.3k total citations
48 papers, 2.7k citations indexed

About

Emmanuel Hanon is a scholar working on Immunology, Epidemiology and Agronomy and Crop Science. According to data from OpenAlex, Emmanuel Hanon has authored 48 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 25 papers in Epidemiology and 16 papers in Agronomy and Crop Science. Recurrent topics in Emmanuel Hanon's work include T-cell and Retrovirus Studies (21 papers), Animal Disease Management and Epidemiology (16 papers) and Influenza Virus Research Studies (14 papers). Emmanuel Hanon is often cited by papers focused on T-cell and Retrovirus Studies (21 papers), Animal Disease Management and Epidemiology (16 papers) and Influenza Virus Research Studies (14 papers). Emmanuel Hanon collaborates with scholars based in Belgium, United Kingdom and Japan. Emmanuel Hanon's co-authors include Charles R. M. Bangham, Graham P. Taylor, Yuetsu Tanaka, Jonathan Weber, Philippe Moris, Geert Leroux‐Roels, Becca Asquith, Mamadou Dramé, Isabel Leroux‐Roels and Peter Goon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Emmanuel Hanon

47 papers receiving 2.6k citations

Peers

Countries citing papers authored by Emmanuel Hanon

Since Specialization

Citations

This map shows the geographic impact of Emmanuel Hanon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Hanon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Hanon more than expected).

Fields of papers citing papers by Emmanuel Hanon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Hanon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Hanon. The network helps show where Emmanuel Hanon may publish in the future.

Co-authorship network of co-authors of Emmanuel Hanon

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Hanon. A scholar is included among the top collaborators of Emmanuel Hanon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Hanon. Emmanuel Hanon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vaccinology in the post−COVID-19 era 2021 ·Proceedings of the National Academy of Sciences ·Rino Rappuoli, Ennio De Gregorio, Giuseppe Del Giudice, Sanjay Phogat, Simone Pecetta, Mariagrazia Pizza, Emmanuel Hanon	60
2	Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks 2020 ·Health Security ·(unknown), Isabelle Deschamps, (unknown), Julie L. Gerberding, Emmanuel Hanon, (unknown), John W. Shiver, Julia Spencer, Johan Van Hoof	27
3	Sustainable vaccine development: a vaccine manufacturer's perspective 2018 ·Current Opinion in Immunology ·Rino Rappuoli, Emmanuel Hanon	21
4	Towards an evidence based approach for the development of adjuvanted vaccines 2017 ·Current Opinion in Immunology ·Derek T. O’Hagan, Leonard R. Friedland, Emmanuel Hanon, Arnaud M. Didierlaurent	83
5	Narcolepsy and A(H1N1)pdm09 vaccination 2013 ·Human Vaccines & Immunotherapeutics ·Robbert van der Most, Marcelle Van Mechelen, Éric Destexhe, Martine Wettendorff, Emmanuel Hanon	11
6	Long-term persistence of humoral and cellular immune responses induced by an AS03_A-adjuvanted H1N1 2009 influenza vaccine 2013 ·Human Vaccines & Immunotherapeutics ·Pierre Van Damme, (unknown), (unknown), Emmanuel Hanon, Philippe Moris, François Roman, Paul Gillard	9
7	Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets 2011 ·Vaccine ·Benoı̂t Baras, Leon de Waal, Koert J. Stittelaar, (unknown), Sandra L. Giannini, Edwin J. B. Veldhuis Kroeze, Judith M. A. van den Brand, Geert van Amerongen, James H. Simon, Emmanuel Hanon, Sally Mossman, Albert D. M. E. Osterhaus	22
8	Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets 2011 ·Vaccine ·Benoı̂t Baras, Koert J. Stittelaar, Thijs Kuiken, (unknown), (unknown), Sandra L. Giannini, Leon de Waal, Geert van Amerongen, James H. Simon, Albert D. M. E. Osterhaus, Emmanuel Hanon, Sally Mossman	16
9	Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study 2009 ·Vaccine ·Isabel Leroux‐Roels, François Roman, (unknown), Cathy Maes, Fien De Boever, Mamadou Dramé, Paul Gillard, Robbert van der Most, Marcelle Van Mechelen, Emmanuel Hanon, Geert Leroux‐Roels	114
10	Vaccination strategies against influenza. 2009 ·PubMed ·Emmanuel Hanon	4
11	Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine 2008 ·PLoS ONE ·Benoı̂t Baras, Koert J. Stittelaar, James H. Simon, (unknown), Sally Mossman, F.H.M. Pistoor, Geert van Amerongen, Martine Wettendorff, Emmanuel Hanon, Albert D. M. E. Osterhaus	142
12	Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only 2006 ·Vaccine ·Sandro Giannini, Emmanuel Hanon, Philippe Moris, Maxime Vanmechelen, (unknown), Francis Dessy, Marc Fourneau, Brigitte Colau, (unknown), (unknown)	391
13	Human T Cell Lymphotropic Virus Type I (HTLV-I)-Specific CD4+ T Cells: Immunodominance Hierarchy and Preferential Infection with HTLV-I 2004 ·The Journal of Immunology ·Peter Goon, Tadahiko Igakura, Emmanuel Hanon, Angelina J. Mosley, (unknown), Amanda Barnard, (unknown), Yuetsu Tanaka, Graham P. Taylor, Jonathan Weber, Charles R. M. Bangham	60
14	Prostatic androgen repressed message‐1 (PARM‐1) may play a role in prostatic cell immortalisation 2003 ·The Prostate ·Anne Cornet, Emmanuel Hanon, Éric Reiter, (unknown), (unknown), Benoît Hennuy, Georges Hennen, (unknown)	19
15	Use of PCR and immunofluorescence to detect bovine herpesvirus 1 recombinants 2001 ·Journal of Virological Methods ·Frédéric Schynts, Alain Vanderplasschen, Emmanuel Hanon, F.A.M. Rijsewijk, J.T. van Oirschot, Étienne Thiry	15
16	High Frequency of Viral Protein Expression in Human T Cell Lymphotropic Virus Type 1-Infected Peripheral Blood Mononuclear Cells 2000 ·AIDS Research and Human Retroviruses ·Emmanuel Hanon, Becca Asquith, Graham P. Taylor, Yuetsu Tanaka, Jonathan Weber, Charles R. M. Bangham	34
17	Bovine Herpesvirus 1-Induced Apoptotic Cell Death: Role of Glycoprotein D 1999 ·Virology ·Emmanuel Hanon, Günther M. Keil, Sylvia van Drunen Littel‐van den Hurk, Philip Griebel, Alain Vanderplasschen, Frans A.M. Rijsewijk, L. A. Babiuk, (unknown)	20
18	Optimization of murine CD8+ cytotoxic T-lymphocyte responses to pseudorabies virus 1997 ·Journal of Immunological Methods ·(unknown), (unknown), (unknown), Martine Denis, Alain Vanderplasschen, Emmanuel Hanon, P.-P. Pastoret, (unknown)	2
19	The use of flow cytometry for concomitant detection of apoptosis and cell cycle analysis 1996 ·Open Repository and Bibliography (University of Liège) ·Emmanuel Hanon, Alain Vanderplasschen, Paul-Pierre Pastoret	8
20	The role of glycoproteins gC, gE, gI and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1 1996 ·Veterinary Microbiology ·Martine Denis, Emmanuel Hanon, Frans A.M. Rijsewijk, M.J. Kaashoek, J.T. van Oirschot, Étienne Thiry, Paul-Pierre Pastoret	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact